One Size Doesn’t Fit All: COVID-19 Vaccines and Immunocompromised Patients


Authors: Stephanie Desmon  Public Health On Call  Johns Hopkins Center for Communication Programs HOW CAN WE PROTECT THOSE WHO ARE IMMUNOCOMPROMISED? We’re doing two things. First, we’re working on the vaccine aspect. We got NIH funding to run a clinical trial of people who thus far have failed to reach a reasonable antibody level with whatever […]

Omicron sub-variants BA.4 and BA.5 account for up to 13% of COVID variants in U.S. – CDC


Authors: Mrinalika Roy Reuters The BA.4 and BA.5 sub-variants of Omicron are estimated to make up nearly 5% and 8% of the coronavirus variants in the United States as of June 4, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday. The two sublineages, which were added to the World Health Organization’s […]

Mount Sinai researchers develop a rapid test to measure immunity to COVID-19


New blood assay provides critical information for revaccination strategies in vulnerable individuals Peer-Reviewed Publication THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring […]

Ocular Adverse Events After COVID-19 Vaccination


Authors: Xin Le Ng, MBBS, a Bjorn Kaijun Betzler, MBBS, b Ilaria Testi, MD, c Su Ling Ho, FRCS, a Melissa Tien, FRCOphth, a Wei Kiong Ngo, FRCOphth, a Manfred Zierhut, PhD, d Soon Phaik Chee, FRCSEd, e , f , g Vishali Gupta, PhD, h Carlos E Pavesio, FRCOphth, b Marc D. de Smet, PhD, i , j and Rupesh Agrawal, FRCS a , b , e , f , g , k Ocul Immunol Inflamm. 2021 : 1–9. Published online 2021 Sep 24. doi: 10.1080/09273948.2021.1976221 PMCID: PMC8477588 PMID: 34559576 ABSTRACT […]

Lifestyle risk behaviors among adolescents: a two-year longitudinal study of the impact of the COVID-19 pandemic


Authors: Anne Gardner1, Jennifer Debenham1, Nicola Clare Newton1, Cath Chapman Fiona Elizabeth Wylie2, Bridie Osman1, Maree Teesson, Katrina Elizabeth Champion The British Medical Journal Abstract Objective To examine changes in the prevalence of six key chronic disease risk factors (the “Big 6”), from before (2019) to during (2021) the COVID-19 pandemic, among a large and geographically diverse sample of adolescents, and […]

Risk of new‐onset psychiatric sequelae of COVID‐19 in the early and late post‐acute phase


Authors: Ben Coleman, 1 , 2 Elena Casiraghi, 3 , 4 Hannah Blau, 1 Lauren Chan, 5 Melissa A. Haendel, 6 Bryan Laraway, 6 Tiffany J. Callahan, 6 Rachel R. Deer, 7 Kenneth J. Wilkins, 8 Justin Reese, 9 and Peter N. Robinson 1 , 2 World Psychiatry. 2022 Jun; 21(2): 319–320 2022 May 7. doi: 10.1002/wps.20992 PMCID: PMC9077621 PMID: 35524622 Recent publications have documented that a proportion of COVID‐19 patients develop psychiatric symptoms during or after acute infection 1 . We investigated this risk in the […]

What to know about shingles and the COVID-19 vaccine


Authors:  Alana Biggers, M.D., MPH —  Carolyn Farnsworth on January 24, 2022 Medical News Today Shingles is an uncomfortable common condition that causes a characteristic rash, among other symptoms. Some studies suggest a link between COVID-19 vaccines and reactivation of the virus that causes shingles. While evidence suggests this could be possible, it is at the very least […]

Scientists propose cause of symptoms, treatment for long COVID-19


Authors: Gary Van Beusekom | News Writer | CIDRAP News   Posted June 10, 2022 Two studies to be presented at upcoming professional society meetings suggest that some long COVID-19 symptoms may be related to the effect of SARS-CoV-2 on the vagus nerve and that the use of enhanced external counterpulsation (EECP)—which increases blood flow—can improve […]

COVID long-haulers: Study shows who is most at risk, impact on local communities


Authors:  Hiroshima University Medical Express Posted June 9. 2022 A Japanese research team looking at COVID-19’s lingering impacts on survivors and local communities found that having a mild case of COVID-19, smoking status, comorbidities, or your sex aren’t significant predictors to tell if you are less likely to develop long-term symptoms, but age is. “The […]

COVID-19: Understanding long COVID


Authors: Emory News Center For some individuals, the road to recovery from COVID-19 is long. While most people recover from mild COVID-19 symptoms over the course of one to two weeks, “long-haul” patients can suffer from lingering symptoms for months on end. This syndrome, called post-acute COVID-19 or “long COVID,” can have devastating effects on […]